Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
DOW, S&P, NAS, and PPHM up over 4%
No replies required.
I have scottrade and i received all the material via email.
Thanks.
All the best of luck.
Joe K.
Ok, all the best of luck.
Joe K.
I'm not negative.
I played and won and lost.
I just said look at the pr history
and then what actually happened.
Look at the mayo clinic fiasco.
Look at the pr history, not the price history.
Look at what they said.
I was in earlier in the year.
Made money, got out.
then got back in and lost money.
I got out at .40 and never looked back.
Look at the recent history over
the last 6 months.
Joe K.
I lost some, I got out at .40
Happy i did.
If you look into the history of this
company you'll stay on the sidelines.
Joe K.
You tried.
Those who ignore history
are destined to repeat it.
Good Luck to All.
Joe K.
Nice close.
Maybe.
Nevermind.
Joe K.
I think all the pumpers have left.
ScottradeElite is still up.
I think you are the only one not drinking the coolaid.
Has Peregrine had a live webcast with replay
at previous Healthcare Conferences?
Thanks,
Joe K.
*DJ Peregrine Reports Promising 20.7 Mo Median Overall Survival From Phase II Advanced Breast Cancer Trial
*DJ Amarin Drug-Patent Application Rejected By US Patent Office
(MORE TO FOLLOW) Dow Jones Newswires
August 17, 2011 15:42 ET (19:42 GMT)
Copyright (c) 2011 Dow Jones & Company, Inc.- -
03 42 PM EDT 08-17-11
*DJ Amarin Drug-Patent Application Rejected By US Patent Office
(MORE TO FOLLOW) Dow Jones Newswires
August 17, 2011 15:42 ET (19:42 GMT)
Copyright (c) 2011 Dow Jones & Company, Inc.- -
03 42 PM EDT 08-17-11
SGEN's antibody sounds like an armed Bavi.
Used for lymphoma.
Joe K.
Premarket 2.29, News?
There is buy and sell volume.
if you go to IHUB trades a
trade that goes for the ask price is considered a buy
a trade that goes for the bid is considered a sell
Thanks,
Dude
The way it was explained to me.
with the bid and ask price.
If the trade happens at the bid its a sell.
If the trade happens wat the ask its a buy.
Joe K.
Kei,
Thanks for your indepth response.
Like most that populate Sheff and FDA
we like the same stuff.
Thanks again,
Joe K.
Kei,
I can't pm.
Thanks for the response.
Joe K.
Kei,
Thanks for your response.
What do you think about the SEC filings
and the association with Epic Parma and Epic investments.
They seem to have taken a large position in ELTP.
Thanks,
Joe K.
Are you in ELTP?
Epic Pharma LLC and Epic Investments LLC
both located in Queens NY in the same building
and their officers are buying big into Elite.
They also do alot of business with Elite.
Found from the SEC documents.
www+nasdaq.com/asp/quotes_sec.asp?symbol=ELTP&selected=ELTP
now 1.64
6500 shares traded last 1.25
1.22 premarket.
Elite Pharmaceuticals Announces Manufacturing and Supply Agreement With
Mikah Pharma, LLC
NORTHVALE, N.J., Jun 6, 2011 (GlobeNewswire via COMTEX) -- Elite
Pharmaceuticals, Inc. ("Elite") (OTCBB:ELTP) today announced that it has entered
into a commercial Manufacturing and Supply Agreement with Mikah Pharma, LLC
("Mikah"). Under the terms of the agreement, Elite will perform the laboratory
stability studies, manufacturing and packaging for two generic products:
Isradipine Capsules USP, 2.5 mg and 5 mg and Phendimetrazine Tartrate Tablets
USP, 35 mg.
Elite will be compensated at an agreed upon transfer price for the manufacturing
and packaging of the products. For the Isradipine product, Elite will receive a
10% royalty on net profits of the finished products. Elite will also receive a
onetime milestone payment for each product for the work associated with the
technology transfer.
"The Mikah agreement represents Elite's continuing progress in utilizing our
manufacturing infrastructure and expertise to generate revenues," commented
Jerry Treppel, Chairman and CEO.
The Annual Meeting of Stockholders of Fibrocell Science, Inc. (“Fibrocell”), which was originally scheduled for 10:00 a.m. on June 1, 2011, has been postponed and rescheduled for 10:00 a.m. on June 15, 2011. The Annual Meeting will be held at 405 Eagleview Blvd., Exton, Pennsylvania 19341. Fibrocell rescheduled the Annual Meeting due to an inadvertent delay in the mailing of its original notice and proxy statement by the third party Fibrocell retained to complete such mailing. Fibrocell decided to postpone the Annual Meeting so that its stockholders have sufficient time to review the notice and proxy statement and to ensure that a quorum of stockholders is present at the Annual Meeting. The close of business on April 25, 2011 will remain as the record date for the determination of stockholders entitled to notice of and to vote at the Annual Meeting and at any and all postponements or adjournments thereof. In addition, no change has been made to the proposals to come before the Annual Meeting, which were presented in the proxy statement that Fibrocell filed with the Securities and Exchange Commission on April 29, 2011.
It is a poster presentation with an oral discussion later.
Joe K.
I bought back and I am still holding.
Best of luck.
Joe K.
http://cchwallstreet.com/AMEXtools/PlatformViewer.asp?SelectedNode=chp_1_1_1&manual=/AMEX/CompanyGuide/amex-company-guide/
(b) Stock Price/Market Value of Shares Publicly Held—The Exchange requires a minimum market price of $3 per share for applicants seeking to qualify for listing pursuant to Section 101 (a), (b) or (d), a minimum market price of $2 per share for applicants seeking to qualify for listing pursuant to Section 101(c), and $3,000,000 aggregate market value of publicly held shares for applicants seeking to qualify for listing pursuant to Section 101(a).
Actually a 260k AH trade. Hmmmm
Sometimes you can't win.
You get beat up over simple observations.
GLTA
Joe K.
Instead of trading it should be called waiting.
50 day moving average.
It should be support.
It should bounce off of that.
If it falls below that, its bad.
I show it at about 7.90